bioRxivBioinformaticsPreprint
From Latent Manifolds to Functional Probes: An Interpretable, Kinome-Scale Generative Machine Learning Framework for Family-Targeted Kinase Inhibitor Design
Abstract
The design of selective kinase inhibitors remains a formidable challenge due to the high structural conservation of the ATP-binding site across the kinome. While modern generative AI has enabled rapid exploration of chemical space, many advanced models operate as black boxes, obscuring the chemical rationale behind design choices and limiting interpretability. To explore these bottlenecks, we present a modular, generative framework for de novo design of SRC kinase inhibitors, integrating ChemVAE-based latent space modeling, a chemically interpretable Kinase Inhibition Likelihood (KIL) scoring function, Bayesian optimization, and cluster-guided local neighborhood sampling. The results demonstrate that kinase inhibitors spontaneously organize into a coherent, low-dimensional manifold in latent space, with SRC acting as a structural "hub" that enables rational scaffold transformation. Our local neighborhood sampling-based approach successfully converts inhibitors from other kinase families (notably LCK) into novel SRC-like chemotypes, with LCK-derived molecules accounting for [~]40% of high-similarity outputs. Critically, we expose a fundamental representation gap: despite aromatic ring count being a top KIL feature, SMILES-based generation systematically fails to access multi-ring pharmacophores characteristic of clinical kinase inhibitors. This limitation cannot be overcome by scoring refinement alone, demanding topology-aware representations. Our framework also demonstrates that unbiased exploration paired with cluster-guided sampling outperforms active-biased optimization, which traps search in narrow local optima. By exposing representational gaps and showcasing scaffold-aware navigation of latent space, this study argues for hybrid systems that combine the diagnostic transparency of interpretable machine learning frameworks with the generative power of modern architectures.
- research focus: drug response / drug discovery
- approach: deep learning
- approach: variational autoencoder
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Integrating Drug-like Moieties and Binding Site Evolution for Kinase Inhibitor Prediction Using Ensemble Learning Models
Weilin Lin, Yen-Chao Hsu, Jinn‐Moon Yang·bioRxiv·May 28, 2025
- Using Domain-Knowledge to Assist Lead Discovery in Early-Stage Drug Design
Tirtharaj Dash, Ashwin Srinivasan, … Arijit Roy·Lecture notes in computer sciencePeer-reviewed·Jan 1, 2022
- Kinase-Inhibitor Binding Affinity Prediction with Pretrained Graph Encoder and Language Model
Xudong Guo, Zixu Ran, Fuyi Li·Briefings in BioinformaticsPeer-reviewed·Jun 25, 2025
- Systematic Benchmarking of AI-Based Molecular Generation Models for Structure-Based Drug Design
Himansu Kumar, Zhengxiao Yang, … Xiaobo Zhou·bioRxiv·Aug 20, 2026
- SHARP: Generating Synthesizable Molecules via Fragment-based Hierarchical Action-space Reinforcement Learning for Pareto Optimization
Jeonghyeon Kim, Seongok Ryu, … Chaok Seok·bioRxiv·Jul 18, 2025
- Progress Towards a Public Chemogenomic Set for Protein Kinases and a Call for Contributions
D. H. Drewry, C. I. Wells, … T. M. Willson·bioRxiv·Jan 31, 2017